Dynavax Technologies Corporation Made Headway
Dynavax Technologies Corporation (DVAX:NASDAQ) soared at $15.38, representing a gain of 38.2%. On Wed, Dec 24, 2025, DVAX:NASDAQ touched a New 2-Week High of $15.38. The stock got featured on our News Catalysts scanner on Wed, Dec 24, 2025 at 06:04 PM in the 'MISCELLANEOUS' category. From Wed, Dec 10, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
About Dynavax Technologies Corporation (DVAX:NASDAQ)
Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor ("TLR") stimulation.
Top 10 Gainers:
- Omeros Corporation (OMER:NASDAQ), 75.54%
- SRAX, Inc. (SRAX:NASDAQ), 67.5%
- Santech Holdings Limited (STEC:NASDAQ), 59.38%
- Northann Corp. (NCL:NYSEMKT), 49.45%
- EUDA Health Holdings Limited (EUDA:NASDAQ), 44.27%
- Safe and Green Development Corporation (SGD:NASDAQ), 42.26%
- Dynavax Technologies Corporation (DVAX:NASDAQ), 38.19%
- Multi Ways Holdings Limited (MWG:NYSEMKT), 38.13%
- Indaptus Therapeutics, Inc. (INDP:NASDAQ), 33.84%
- Sidus Space, Inc. (SIDU:NASDAQ), 33.33%